ORIC Pharmaceuticals Inc. (ORIC)
NASDAQ: ORIC
· Real-Time Price · USD
10.41
-0.05 (-0.48%)
At close: Sep 25, 2025, 3:59 PM
10.41
0.00%
After-hours: Sep 25, 2025, 04:20 PM EDT
-0.48% (1D)
| Bid | 10.37 |
| Market Cap | 1.01B |
| Revenue (ttm) | 1.07M |
| Net Income (ttm) | -137.25M |
| EPS (ttm) | -1.89 |
| PE Ratio (ttm) | -5.51 |
| Forward PE | -6.31 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 10.59 |
| Volume | 824,385 |
| Avg. Volume (20D) | 1,126,638 |
| Open | 10.30 |
| Previous Close | 10.46 |
| Day's Range | 10.19 - 10.65 |
| 52-Week Range | 3.90 - 14.67 |
| Beta | 1.63 |
| Ex-Dividend Date | n/a |
About ORIC
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ORIC
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ORIC stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 months ago
+33.5%
Oric Pharmaceuticals shares are trading higher aft...
Unlock content with
Pro Subscription
4 months ago
+3.29%
ORIC Pharmaceuticals shares are trading higher after the company announced preliminary efficacy and safety data from its ongoing Phase 1b trial of ORIC-944. Additionally, the company announced a $125 million private placement, which was priced at an 18% premium to its 10-day trailing volume-weighted average price.
